Showing results (1781-1790 of 2,360) with videos related to
Sort By:
Pageof 236
Frontiers in Pediatrics|May 14, 2025
Case Report: Clinical manifestations of uncommon monogenic disorders: revisiting activated phosphoinositide 3-kinase delta syndrome 2Oded Shamriz, Amarilla Mandola, Amos J Simon, et al.Plos One|March 28, 2013
Dectin-1 regulates IL-10 production via a MSK1/2 and CREB dependent pathway and promotes the induction of regulatory macrophage markersSuzanne E Elcombe, Shaista Naqvi, Mirjam W M Van Den Bosch, et al.Investigational New Drugs|July 30, 1999
A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumorsJ D Berlin, D B Alberti, R Z Arzoomanian, et al.JAMA|December 2, 1999
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDsM J Langman, D M Jensen, D J Watson, et al.Journal of Pharmaceutical Sciences|February 15, 2001
Antigen levels and antibody titers after DNA vaccinationM Chastain, A J Simon, K A Soper, et al.Cancer Treatment Reports|December 1, 1987
Phase I study of taxol administered as a short i.v. infusion daily for 5 daysJ L Grem, K D Tutsch, K J Simon, et al.Vaccine|May 5, 2010
Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic reviewKatrina F Brown, J Simon Kroll, Michael J Hudson, et al.Science (New York, N.Y.)|March 29, 2014
Conversion of channelrhodopsin into a light-gated chloride channelJonas Wietek, J Simon Wiegert, Nona Adeishvili, et al.European Journal of Cell Biology|April 12, 2008
LAP2zeta binds BAF and suppresses LAP2beta-mediated transcriptional repressionSigal Shaklai, Raz Somech, Einav Nili Gal-Yam, et al.Clinical Pharmacology and Therapeutics|October 1, 1983
Dynamics of propranolol dosing schedulesJ B Coelho, D Dvornik, J F Mullane, et al.Pageof 236